Data / Drug companies / Vilazodone hydrochloride
Vilazodone hydrochloride: 13 companies and 36 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Vilazodone hydrochloride is listed in the FDA National Drug Code Directory by 13 companies, with 36 products in commercial distribution. 33 of the products (91.7%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, film coated; tablet, and the newest product started marketing on September 16, 2024.
The request: Get every company that lists vilazodone hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 13
- Products
- 36
- Generic (ANDA) products
- 33 (91.7%)
- Application numbers
- 6
- Routes
- Oral
- Brand names
- Viibryd
- openFDA record search
- api.fda.gov
Companies that list vilazodone hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Accord Healthcare Inc. | 3 | tablet | Generic drugs (ANDA) | June 4, 2022 |
| Alembic Pharmaceuticals Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | June 4, 2022 |
| Alembic Pharmaceuticals Limited | 3 | tablet, film coated | Generic drugs (ANDA) | June 4, 2022 |
| Allergan, Inc. | 3 | tablet | New drug applications (NDA) | April 29, 2011 |
| Apotex Corp. | 3 | tablet | Generic drugs (ANDA) | October 26, 2023 |
| Cipla USA Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | January 23, 2023 |
| Exelan Pharmaceuticals Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | December 1, 2022 |
| Golden State Medical Supply, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | September 30, 2019 |
| NorthStar RxLLC | 3 | tablet | Generic drugs (ANDA) | July 7, 2023 |
| Novadoz Pharmaceuticals LLC | 3 | tablet | Generic drugs (ANDA) | July 7, 2023 |
| Teva Pharmaceuticals, Inc. | 3 | tablet, film coated | Generic drugs (ANDA) | June 6, 2022 |
| Preferred Pharmaceuticals Inc. | 2 | tablet | Generic drugs (ANDA) | September 16, 2024 |
| Proficient Rx LP | 1 | tablet | Generic drugs (ANDA) | October 26, 2023 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, film coated | 18 | 50% |
| Tablet | 18 | 50% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 33 | 91.7% |
| New drug applications (NDA) | 3 | 8.3% |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.